UnknownNot Applicable

Comparative Study of Three Different Embryo Transfer Media in ICSI Cycles

150 participantsStarted 2016-05

Plain-language summary

The study design is a prospective randomized uncontrolled clinical trial. It will include 150 cases. The aim of this study is to compare the efficacy of three different media used for embryo transfer regarding "chemical and clinical" pregnancy rate, implantation rate and ongoing pregnancy and miscarriage rates in IVF and ICSI cycles. The three different embryo transfer media are: 1. Hyaluronan-enriched medium "Embryo Glue®" 2. 30% Protein-supplemented Culture medium "Global Total®" 3. Autologous Follicular Fluid (a Novel technique) In order to establish the optimal media for embryo transfer

Who can participate

Age range18 Years – 35 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age: 18-35 years
✓. Body mass index (BMI): ≤ 30
✓. Anti-mullerian hormone (AMH): 1.1 - 3
✓. No gynecological problem e.g. fibroid, endometriosis, uterine polyp, hydrosalpinx or adenomysis
✓. Male factor: mild to moderate oligo or asthenospermia

Exclusion criteria

✕. Age: \<18 years or \>35 years
✕. Body mass index (BMI): \>30
✕. Anti-mullerian hormone (AMH): \<1.1 or \>3
✕. gynecological problem e.g. fibroid, endometriosis, uterine polyp, hydrosalpinx or adenomysis will be excluded
✕. Male factor: Abnormal sperm morphology; (globozoospermia and pin-point sperm) and azoospermia; (whether obstructive or non-obstructive) will be excluded
✕. Patients with recurrent implantation failure

What they're measuring

Chemical pregnancy rate

Timeframe: 14 days after embryo transfer

Trial details

NCT IDNCT02792673

SponsorSouth Valley University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-10

View on ClinicalTrials.gov More Improvement of Embryo Transfer Technique trials